Travere Therapeutics, Inc. (NASDAQ:TVTX) Q2 2023 Earnings Call Transcript

So, there’s actually several different factors that are likely to expand the addressable population not just in the label expansion. So, we can certainly talk about that in future quarters, but we do believe that there are several meaningful factors that should expand the population moving forward.

Ed Arce: Great. That’s helpful Thank you, Eric.

Eric Dube: Thank you.

Operator: This concludes today’s question-and-answer session. I will now turn the call back to Naomi Eichenbaum for any additional or closing remarks.

Naomi Eichenbaum: Thank you. This concludes our second quarter update. We look forward to keeping you updated throughout the remainder of the year and speaking with you all again soon. Have a great rest of your evening.

Operator: This concludes today’s call. Thank you for your participation and you may now disconnect.